Activity Overview
Often chronic pain has no cure. It may be nociceptive, neuropathic, or
disease specific. Left untreated, chronic pain may affect sleep, quality of
life, mental health, and productivity. This condition is difficult to diagnose
and manage because an individual’s perception of pain is subjective,
and the cause varies between patients. Managed care pharmacists are
readily available to patients and colleagues for questions regarding pain
management. They can assess the patient’s risk for abuse and optimize
treatment strategies for improved patient outcomes. In addition, they provide
physicians and staff with important information regarding administration,
side effects, drug interaction potential, and efficacy of pharmacologic
agents used to address chronic pain. In order to provide this type
of care, managed care pharmacists need an in-depth understanding of all
the available and emerging technologies and options for pain management.
This activity will focus on the current state of chronic pain management,
various advances in treatment options, and how these issues speak
to pharmacists working in the managed care arena.
Agenda
| 5 minutes |
Welcome, Activity Goals, and Pre-Webcast Outcomes Survey
Bruce R. Canaday, PharmD, FAPhA, FASHP |
| 20 minutes |
Current State of Chronic Pain Management
Robert L. Barkin, PharmD, MBA, FCP, DAAPM |
| 5 minutes |
Question and Answer Session |
| 20 minutes |
New and Emerging Therapies in the Chronic Pain
Category
Charles Argoff, MD |
| 5 minutes |
Question and Answer Session |
| 20 minutes |
Perspectives for the Managed Care Pharmacist
Bruce R. Canaday, PharmD, FAPhA, FASHP |
| 5 minutes |
Question and Answer Session |
| 10 minutes |
Faculty Discussion and Post-Webcast Outcomes Survey |
Goal
This activity has been designed to enhance managed care pharmacists’ understanding
of the existing and emerging pharmacologic treatments for chronic pain
and the implications for managed care; to provide strategies for improving pain
control, risk management, and quality of life; and to identify and manage barriers
associated with opioid therapy in order to provide optimal patient outcomes.
Intended Audience
This activity is designed for managed care pharmacists. No prerequisites required.
Learning Objectives
The University of Tennessee College of Pharmacy takes responsibility for
the content, quality, and scientific integrity of this CPE activity. Upon the
conclusion of this activity, the participant should be able to:
- DIFFERENTIATE existing and emerging pharmacologic treatment
options for chronic pain.
- DEMONSTRATE strategies to improve pain control, manage risk,
and improve quality of life in patients with chronic pain.
- IDENTIFY barriers associated with opioid therapy and methods to
overcome these obstacles to optimize treatment.
- DISCUSS managed care pharmacy implications of new and
emerging technologies and changing use patterns.
Accreditation Statement
The University of
Tennessee College of Pharmacy is accredited by the
Accreditation Council for Pharmacy Education to provide continuing
education for pharmacists.
Credit Designation Statement
 This application-based activity is sponsored by the University of
Tennessee College of Pharmacy who is accredited by
the Accreditation Council for Pharmacy Education as a provider
of continuing pharmacy education. Successful completion of this
application-based educational activity will provide 1.5 contact
hours credit (0.15 CEUs). A statement of CPE credit will be
available online immediately following successful completion of
the activity. Successful completion includes attending the on-line
session, completing the pre- and post-test, and completing the
educational activity evaluation. ACPE Program #064-000-09-203-L01-P.
Faculty
Bruce R. Canaday, PharmD,
FAPhA, FASHP (Chair)
Clinical Professor and Vice-Chair
Division of Pharmacy Practice and Experiential Education
University North Carolina Eshelman
School of Pharmacy
Chapel Hill, North Carolina
Robert L. Barkin, PharmD,
MBA, FCP, DAAPM
Professor, Rush Medical College
Faculty of Anesthesiology, Family
Medicine, and Pharmacology
Rush University Medical Center
Clinical Pharmacologist, Northshore
University Health System—Skokie,
Evanston Hospitals, Pain Centers, and
The Department of Anesthesiology
Chicago, Illinois
Charles Argoff, MD
Director, Comprehensive Pain Program
Professor of Neurology
Albany Medical College
Albany, New York
Policy on Faculty and Provider Disclosure
It is the policy of The University of Tennessee College of
Pharmacy that the faculty and provider disclose real or apparent
conflicts of interest relating to the topics of this educational
activity, and also disclose discussions of unlabeled/unapproved
uses of drugs or devices during the presentation(s). Detailed disclosures
will be made in the course presentations.
Americans with Disabilities Act (ADA)
The
University of Tennessee College of Pharmacy fully complies
with the legal requirements of the ADA and the rules and regulations
thereof. Please notify us if you have any special
needs.
Grievance Policy
A participant, sponsor, faculty member,
or other individual wanting to file a grievance with
respect to any aspect of an educational activity sponsored or
cosponsored by The University of Tennessee College of
Pharmacy may contact the Associate Dean for Continuing
Education in writing. The grievance will be reviewed and a
response will be returned within 45 days of receiving the written
statement. If not satisfied, an appeal to the Dean of the
College of Pharmacy can be made for a second level review.
Fee Information
There is no fee for this educational activity. |
